Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Eric A. F. Simões, Shabir A. Madhi, William J. Muller, +17

The Lancet Child & Adolescent Health

AsthmaRespiratory Syncytial VirusRespiratory DiseasesPediatricsRespiratory Infection +7

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

Steve Cunningham, Pedro A. Piedra, Federico Martinón‐Torres, +61

The Lancet Respiratory Medicine

Respiratory Syncytial VirusRespiratory DiseasesHospitalised ChildrenRespiratory ComplicationsPediatrics +6

Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial

Miroslava Bosheva, István Tokodi, Aleksander Krasnow, +7

Frontiers in Nutrition

Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

Diana Bilton, Tacjana Pressler, Isabelle Fajac, +83

Journal of Cystic Fibrosis

Respiratory InfectionInfectious Respiratory DiseaseAntimicrobial ChemotherapyMicrobiologyInfection Control +3

Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season

Ron Dagan, Laura L. Hammitt, Beatriz Seoane Núñez, +13

Journal of the Pediatric Infectious Diseases Society

NeonatologyRespiratory Virus ImmunityEnhanced DiseasePreventive MedicinePediatric Epidemiology +15

Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: The rainbow study

Søren Pedersen, Paul Potter, Svetoslav Dachev, +5

Respiratory Medicine

AsthmaAllergyAllergy MedicinePediatricsPediatric Lung Disease +5

Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial

Anna Płoszczuk, Miroslava Bosheva, Kay Spooner, +2

Therapeutic Advances in Respiratory Disease

Blood-Based Gene Expression in children with Autism spectrum disorder

Hristo Ivanov, Stoyanova Vili, Nikolay Popov, +2

Biodiscovery

A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients

Miroslava Bosheva, Rusudan Gujabidze, Éva Károly, +4

The Pediatric Infectious Disease Journal

Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients

Christopher M. Rubino, Mark J. Polak, Sebastian Schröpf, +13

The Pediatric Infectious Disease Journal